Drug Detail:Ipratropium nasal (Ipratropium nasal [ ip-ra-tro-pee-um ])
Drug Class: Nasal antihistamines and decongestants
Ipratropium Levels and Effects while Breastfeeding
Summary of Use during Lactation
Although no published data exist on the use of ipratropium, its use produces negligible maternal serum levels and any drug in breastmilk would not be absorbed by the infant. The risk to the breastfed infant of maternal ipratropium inhalation is small.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Albuterol, Salmeterol
Substance Identification
Substance Name
Ipratropium
CAS Registry Number
60205-81-4
Drug Class
-
Breast Feeding
-
Lactation
-
Anti-Asthmatic Agents
-
Bronchodilator Agents
-
Muscarinic Antagonists
-
Parasympatholytics
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification